MTOR and tuberous sclerosis: The use of mTOR inhibitors, particularly everolimus, may be considered an important hallmark to treat children (>3 years old) with subependymal giant cell astrocytomas (SEGAs) associated with tuberous sclerosis complex (TSC) and not amenable to surgical treatment.